IT1284758B1 - Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea. - Google Patents

Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea.

Info

Publication number
IT1284758B1
IT1284758B1 IT96TO000710A ITTO960710A IT1284758B1 IT 1284758 B1 IT1284758 B1 IT 1284758B1 IT 96TO000710 A IT96TO000710 A IT 96TO000710A IT TO960710 A ITTO960710 A IT TO960710A IT 1284758 B1 IT1284758 B1 IT 1284758B1
Authority
IT
Italy
Prior art keywords
analogs
stimulate
vitamin
synthesis
derivatives
Prior art date
Application number
IT96TO000710A
Other languages
English (en)
Inventor
Marc Dumas
Frederic Bonte
Alain Meybeck
Catherine Chaudagne
Original Assignee
Lvmh Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvmh Rech filed Critical Lvmh Rech
Publication of ITTO960710A1 publication Critical patent/ITTO960710A1/it
Application granted granted Critical
Publication of IT1284758B1 publication Critical patent/IT1284758B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
IT96TO000710A 1995-08-25 1996-08-20 Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea. IT1284758B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510093A FR2737971B1 (fr) 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Publications (2)

Publication Number Publication Date
ITTO960710A1 ITTO960710A1 (it) 1998-02-20
IT1284758B1 true IT1284758B1 (it) 1998-05-21

Family

ID=9482092

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96TO000710A IT1284758B1 (it) 1995-08-25 1996-08-20 Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea.

Country Status (13)

Country Link
US (1) US5801192A (it)
JP (1) JP4313846B2 (it)
AU (1) AU5407796A (it)
BE (1) BE1009858A5 (it)
CA (1) CA2202629A1 (it)
CH (1) CH690489A5 (it)
DE (1) DE19680859T1 (it)
ES (1) ES2129013B1 (it)
FR (1) FR2737971B1 (it)
GB (1) GB2308811B (it)
IT (1) IT1284758B1 (it)
NL (1) NL1003883C2 (it)
WO (1) WO1996019099A2 (it)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768927B1 (fr) * 1997-10-01 2000-01-21 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
FR2791261A1 (fr) * 1999-03-24 2000-09-29 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogue pour promouvoir la transformation de procollagenes inactifs en collagenes actifs
FR2791259B1 (fr) * 1999-03-24 2001-08-17 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogues pour augmenter le taux de differenciation et/ou de proliferation des cellules de la peau
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
FR2795956B1 (fr) * 1999-07-06 2006-07-14 Inst Evaluation Dermatophysiqu Composition cosmetique pour ameliorer l'elasticite de la peau et lutter contre son vieillissement
WO2001043711A1 (en) * 1999-12-14 2001-06-21 Unilever Plc Cosmetic skin conditioning compositions containing red yeast rice extract
FR2807322B1 (fr) 2000-04-10 2004-02-20 Oreal Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
FR2807320B1 (fr) * 2000-04-10 2002-05-24 Oreal Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
US6468552B1 (en) 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6576248B1 (en) 2000-09-11 2003-06-10 Avon Products, Inc. Pigmented vitamin C composition
WO2003018003A1 (en) * 2001-08-24 2003-03-06 Matthias Rath Ascorbic acid derivatives with essential amino acids, nonessential amino acids that do not occur in protein
EP2241560A3 (en) * 2001-08-24 2014-07-09 Matthias Rath Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
FR2832630B1 (fr) * 2001-11-28 2005-01-14 Oreal Composition cosmetique et/ou dermatologique contenant au moins un actif hydrophile sensible a l'oxydation stabilise par au moins un copolymere de n-vinylimidazole
KR100505105B1 (ko) * 2001-12-20 2005-07-29 샘즈바이오 주식회사 삼중 코팅구조의 비타민 에이씨(레티닐 팔미테이트와순수비타민 씨) 및 그를 함유하는 화장료 조성물
EP1374849B1 (fr) * 2002-06-20 2005-11-23 L'oreal Utilisation cosmétique et/ou dermatologique d'une composition contenant au moins un actif hydrophile sensible à l'oxydation stabilisé par au moins un copolymère d'anhydride maléique
FR2846005B1 (fr) * 2002-10-16 2006-06-23 Maco Pharma Sa Composition pour milieu biologique comprenant de l'erythorbate de sodium
WO2004056383A1 (en) * 2002-12-20 2004-07-08 Council Of Scientific And Industrial Research Herbal composition for cuts, burns and wounds
US7025966B2 (en) 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
JP2005247826A (ja) * 2004-02-04 2005-09-15 Kose Corp デコリン産生促進剤及びそれを含有する皮膚外用剤
KR100868905B1 (ko) * 2004-03-26 2008-11-14 (주)아모레퍼시픽 진세노사이드 ｆ1과 ｅｇｃｇ을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물
WO2007007255A2 (en) * 2005-07-08 2007-01-18 The Procter & Gamble Company Personal care compositions and methods for the beautification of mammalian skin and hair
CA2623725A1 (en) * 2005-09-30 2007-04-12 Omp, Inc. Stable ascorbic acid compositions
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
DE102006035040A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Wirkstoffkombinationen aus Ascorbylverbindung und hydriertem Lecithin
FR2911779B1 (fr) 2007-01-30 2009-04-24 Lvmh Rech Composition contenant un extrait d'ambre
IT1397735B1 (it) * 2010-01-18 2013-01-24 Binda Composizione cosmetica ad attivita' idratante ed antiossidante.
JP5679684B2 (ja) * 2010-03-17 2015-03-04 グンゼ株式会社 Ｄａｎｃｅタンパク質含有組織再生用基材
EP2484387A1 (en) * 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
US20130089641A1 (en) * 2011-10-11 2013-04-11 Sunway Biotech Co., Ltd. Soymilk with Additive of Vitamin C, Vitamin C salt or Vitamin C Stereoisomer
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
ES2625768T3 (es) 2015-03-26 2017-07-20 Université De Bordeaux Método de reconstrucción de piel
ITUB20152183A1 (it) * 2015-07-15 2017-01-15 Germano Laghi Miscela di principi attivi cosmetici per la preparazione di un gel cosmetico e metodo per la preparazione di detto gel
KR102354282B1 (ko) * 2017-05-17 2022-01-21 주식회사 엘지생활건강 에리소르빈산을 포함하는 화장료 조성물
JP2019069912A (ja) * 2017-10-06 2019-05-09 株式会社シャネル化粧品技術開発研究所 非水系皮膚外用組成物およびその製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5262635A (en) * 1975-11-20 1977-05-24 Matsushita Electric Ind Co Ltd Method of producing zinc electrode
JPS6379809A (ja) * 1986-09-22 1988-04-09 Shiseido Co Ltd 皮膚外用剤
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
EP0282746A1 (en) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Method for producing artificial cultured tissue
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
FR2666226B1 (fr) * 1990-08-30 1994-10-28 Jean Noel Thorel Composition protectrice de la peau.
EP0537092A1 (fr) * 1991-10-08 1993-04-14 Patrinove Societe Civile Vecteurs vésiculaires infracellulaires et leurs applications dans les compositions cosmétiques, médicamenteuses et les milieux de culture
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
DE4419783A1 (de) * 1994-06-06 1995-12-07 Asta Medica Ag Haarkur-Pflege-Shampoo
FR2735982B1 (fr) * 1995-06-27 1997-09-19 Lvmh Rech Composition cosmetique ou pharmaceutique contenant un extrait de plantes du genre filicium

Also Published As

Publication number Publication date
JP4313846B2 (ja) 2009-08-12
ITTO960710A1 (it) 1998-02-20
DE19680859T1 (de) 1997-10-02
BE1009858A5 (fr) 1997-10-07
NL1003883C2 (nl) 1997-02-27
FR2737971B1 (fr) 1997-11-14
WO1996019099A2 (fr) 1996-06-27
FR2737971A1 (fr) 1997-02-28
GB2308811A (en) 1997-07-09
GB2308811A8 (en) 1999-05-21
CH690489A5 (fr) 2000-09-29
AU5407796A (en) 1996-07-10
NL1003883A1 (nl) 1997-02-27
JPH10509735A (ja) 1998-09-22
GB2308811B (en) 2000-04-05
GB9708362D0 (en) 1997-06-18
US5801192A (en) 1998-09-01
ES2129013B1 (es) 2000-04-01
WO1996019099A3 (fr) 1997-04-10
CA2202629A1 (en) 1996-06-27
ES2129013A1 (es) 1999-05-16

Similar Documents

Publication Publication Date Title
IT1284758B1 (it) Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea.
FR2680466B3 (fr) Preparation de blanchiment de la peau.
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
IT8449361A1 (it) Composizione cosmetica o dermatologica per la cura della pelle
MX187577B (es) Composiciones para el cuidado de la piel
IT9067204A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ES288234Y (es) Dispositivo para el tratamiento estetico de la piel
FI973124A (fi) D-vitamiinijohdannaisten dermatologinen käyttö
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
IT1243981B (it) Composizioni per il trattamento della pelle contenenti derivati della b-fosfatidilcolina
IT8947667A0 (it) Composizione cosmetica per combattere la cellulite
ES2147576T3 (es) Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson.
ITRM950589A0 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili
IT1211103B (it) Sostanza medicamentosa ad impiego topico per il trattamento delle affezioni provocate dalla seborrea sul cuoio capelluto umano.
IT1225405B (it) Formulazione cosmetica per la cura della pelle.
IT8823099A0 (it) Nuovi analoghi retro-inversi della timopentina, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat
IT8419324A0 (it) Procedimento per la sintesi di derivati n-acilici dell'aspartame.
ITMI920176A0 (it) Dispositivo per l'esecuzione dell'agopuntura cutanea, in particolare per il lenimento di dolori localizzati
IT8823100A0 (it) Nuova sintesi della 2, 2'-a2-bis-ossazolina
IT1229264B (it) Preparato cosmetico per la protezione della pelle
ITMI921785A0 (it) Procedimento per la sintesi dell'1-4-butandiolo
ITMI910967V0 (it) Regolo per la determinazione dell'intensita' del dolore

Legal Events

Date Code Title Description
0001 Granted